Smith & Nephew’s (SN) Overweight Rating Reaffirmed at JPMorgan Chase & Co.

Smith & Nephew (LON:SN)‘s stock had its “overweight” rating reiterated by equities research analysts at JPMorgan Chase & Co. in a research note issued to investors on Tuesday,Digital Look reports. They currently have a GBX 1,180 ($14.44) price objective on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 19.43% from the company’s current price.

Smith & Nephew Trading Down 1.6 %

Shares of LON:SN traded down GBX 16 ($0.20) during trading on Tuesday, reaching GBX 988 ($12.09). 1,904,525 shares of the stock were exchanged, compared to its average volume of 343,671. The company has a market cap of £8.62 billion, a price-to-earnings ratio of 3,659.26, a PEG ratio of 0.46 and a beta of 0.62. The company’s 50 day moving average is GBX 978.94 and its 200-day moving average is GBX 1,073.80. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51.

Insider Activity at Smith & Nephew

In related news, insider John Rogers purchased 71,920 shares of the firm’s stock in a transaction dated Thursday, December 19th. The stock was bought at an average price of GBX 972 ($11.89) per share, for a total transaction of £699,062.40 ($855,436.12). Also, insider Deepak Nath sold 34,033 shares of the firm’s stock in a transaction on Thursday, December 5th. The shares were sold at an average price of GBX 981 ($12.00), for a total transaction of £333,863.73 ($408,545.93). 0.19% of the stock is currently owned by company insiders.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.